Analysis Note
To view the Certificate of Analysis for this product, please visit www.cytiva.com.
Application
The increased capacity of the medium is well suited for purification of Mabs from high-level expression feedstock.
Features and Benefits
Increased dynamic binding capacity with smaller particle size and greater porosity than MabSelect™ medium. MabSelect™ Xtra uses the same recombinant Protein A ligand as MabSelect™ Oriented coupling of recombinant Protein A to the matrix via an engineered C-terminal cysteine enhances IgG binding capacity. Fewer regulatory concerns due to the total absence of mammalian culture in the ligand production and purification. Prepacked HiTrap® columns for process development, screening of purification conditions, and small-scale purification of Mabs.
General description
HiTrap® MabSelect™ Xtra columns are prepacked with MabSelect™ Xtra, a BioProcess medium for capture of monoclonal antbodies from large sample volumes.
Legal Information
MabSelect is a trademark of Cytiva
HiTrap is a registered trademark of Cytiva
This product has met the following criteria: